KATHERINE OWEN: Open Payments
NPI 1801407713 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 14 payments from 8 companies in 2025. Trend: 2023 $232 · 2024 $1,366 · 2025 $460
Food & beverage: $460
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 1 | $115 |
| Medtronic, Inc. | 3 | $107 |
| Ascendis Pharma Endocrinology Inc | 3 | $64 |
| Novo Nordisk Inc | 3 | $64 |
| Dexcom, Inc. | 1 | $35 |
| Tandem Diabetes Care, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $23 |
| KYOWA KIRIN, INC. | 1 | $22 |
Products named: OMNIPOD, MINIMED 780G, Yorvipath, Ozempic, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, TEPEZZA, CRYSVITA.
Industry payments across FL — which companies pay providers there.
